| Market Cap | 771.94M | P/E | - | EPS this Y | -70.90% | Ern Qtrly Grth | - |
| Income | -577.76M | Forward P/E | -5.76 | EPS next Y | 81.60% | 50D Avg Chg | 5.00% |
| Sales | 3.1B | PEG | 0.00 | EPS past 5Y | - | 200D Avg Chg | -12.00% |
| Dividend | N/A | Price/Book | 1.34 | EPS next 5Y | 76.60% | 52W High Chg | -85.00% |
| Recommedations | 3.00 | Quick Ratio | 0.35 | Shares Outstanding | 2.89M | 52W Low Chg | 89.00% |
| Insider Own | 43.43% | ROA | -14.23% | Shares Float | 1.25M | Beta | 0.05 |
| Inst Own | 34.34% | ROE | -429.35% | Shares Shorted/Prior | 577.30K/535.56K | Price | 1.44 |
| Gross Margin | 4.94% | Profit Margin | -18.63% | Avg. Volume | 3,926,569 | Target Price | 0.50 |
| Oper. Margin | -11.67% | Earnings Date | Feb 26 | Volume | 3,027,889 | Change | -1.37% |
Cano Health, Inc. provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement. The company also operates pharmacies, as well as provides dental services in its medical centers. Cano Health, Inc. was founded in 2009 and is headquartered in Miami, Florida. On February 4, 2024, Cano Health, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Cooperstone Elliot | Director Director | Jan 30 | Sell | 2.61 | 22,738 | 59,346 | 516,007 | 02/02/24 |
| Cooperstone Elliot | Director Director | Jan 25 | Sell | 2.69 | 92,619 | 249,145 | 538,745 | 01/29/24 |
| Cooperstone Elliot | Director Director | Jan 22 | Sell | 2.76 | 233,842 | 645,404 | 631,364 | 01/24/24 |
| Cooperstone Elliot | Director Director | Jan 17 | Sell | 2.37 | 200,000 | 474,000 | 865,206 | 01/19/24 |
| Cooperstone Elliot | Director Director | Jan 10 | Sell | 3.54 | 74,171 | 262,565 | 01/12/24 | |
| Cooperstone Elliot | Director Director | Jan 05 | Sell | 3.81 | 75,000 | 285,750 | 74,171 | 01/09/24 |
| Cooperstone Elliot | Director Director | Jan 02 | Sell | 4.61 | 131,833 | 607,750 | 149,171 | 01/04/24 |
| Cooperstone Elliot | Director Director | Dec 27 | Sell | 5.88 | 113,916 | 669,826 | 281,004 | 12/29/23 |
| Cooperstone Elliot | Director Director | Dec 21 | Sell | 5.85 | 137,683 | 805,446 | 394,920 | 12/26/23 |
| Camerlinck Robert | Chief Operating Offi.. Chief Operating Officer | Aug 11 | Sell | 0.7653 | 30,646 | 23,453 | 26,958,642 | 08/15/23 |
| Aguilar Richard | Chief Clinical Offic.. Chief Clinical Officer | May 25 | Sell | 1.35 | 1,275,940 | 1,722,519 | 1,213,984 | 06/13/23 |
| Armstrong David J | See remarks See remarks | Jun 06 | Sell | 1.3756 | 3,163 | 4,351 | 656,626 | 06/07/23 |
| Koppy Brian D | Chief Financial Offi.. Chief Financial Officer | Apr 05 | Sell | 1.2745 | 23,591 | 30,067 | 802,570 | 04/07/23 |
| Gold Lewis | Director Director | Mar 17 | Buy | 6.81 | 300,000 | 2,043,000 | 314,825 | 03/21/22 |
| Aguilar Richard | Chief Clinical Offic.. Chief Clinical Officer | Aug 31 | Buy | 11.96 | 123,406 | 1,475,936 | 123,406 | 08/31/21 |
| Hernandez Marlow | CEO and President CEO and President | Aug 23 | Buy | 9.86 | 210,000 | 2,070,600 | 210,000 | 08/23/21 |